CIMG (CIMG)
OTHER OTC:CIMG
Top Page
CIMG
(OTC:CIMG)
Select Model
Select Model
Rating:41Neutral
Price Target:
$0.04
▼(-96.89% Downside)
Action:UpgradedDate:03/26/26
The score is held down primarily by severe unprofitability and substantial cash burn, alongside a strongly bearish technical setup with price far below key moving averages and weak momentum indicators. Valuation support is limited due to negative earnings (negative P/E) and no dividend yield provided. Corporate events are mixed but skew risky due to the Nasdaq delisting/OTC transition and financing uncertainty.
Positive Factors
Strong revenue growth
Sustained, large top-line growth reflects early commercial traction for medicine-food homology products and computing power offerings. Durable revenue expansion improves the odds of achieving scale, supports channel investment, and creates a foundation to improve margins as fixed costs are leveraged over time.
Negative Factors
Severe cash burn
Large negative operating and free cash flow indicates the business is consuming material cash faster than earnings, forcing dependence on external financing. Persistent cash burn reduces runway, constrains strategic investments, and elevates dilution or refinancing risk over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong revenue growth
Sustained, large top-line growth reflects early commercial traction for medicine-food homology products and computing power offerings. Durable revenue expansion improves the odds of achieving scale, supports channel investment, and creates a foundation to improve margins as fixed costs are leveraged over time.
Read all positive factors
CIMG (CIMG) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$3.33M
Dividend YieldN/A
Average Volume (3M)2.73M
Price to Earnings (P/E)―
Beta (1Y)1.93
Revenue Growth-88.01%
EPS Growth76.01%
CountryUS
Employees33
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)N/A
Shares Outstanding89,971,440
10 Day Avg. Volume1,855,591
30 Day Avg. Volume2,732,844
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)0.17
Price to Sales (P/S)0.81
P/FCF Ratio-0.48
Enterprise Value/Market Cap0.72
Enterprise Value/Revenue0.09
Enterprise Value/Gross Profit13.46
Enterprise Value/Ebitda-0.42
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
CIMG Business Overview & Revenue Model
Company Description
NuZee, Inc., together with its subsidiaries, manufactures, packs, and sells single-serve pour-over coffee and tea bag-style coffee for coffee roasters and food service companies in North America, South Korea, Singapore, Hong Kong, Mainland China, ...
CIMG Financial Statement Overview
Summary
Income Statement
14
Very Negative
Balance Sheet
56
Neutral
Cash Flow
9
Very Negative
| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
CIMG Technical Analysis
Negative
1.22
Price Trends
0.39
Negative
1.21
Negative
3.15
Negative
Market Momentum
-0.11
Negative
25.45
Positive
37.04
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CIMG, the sentiment is Negative. The current price of 1.22 is above the 20-day moving average (MA) of 0.05, above the 50-day MA of 0.39, and below the 200-day MA of 3.15, indicating a bearish trend. The MACD of -0.11 indicates Negative momentum. The RSI at 25.45 is Positive, neither overbought nor oversold. The STOCH value of 37.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CIMG.
CIMG Risk Analysis
CIMG disclosed 3 risk factors in its most recent earnings report. CIMG reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
CIMG Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
57 Neutral | $20.86M | -350.92 | 4089.67% | ― | 0.04% | -65.10% | |
44 Neutral | $27.65M | -1.63 | -48.26% | ― | -1.58% | -78.08% | |
44 Neutral | $16.24M | 19.18 | ― | ― | ― | ― | |
41 Neutral | $3.33M | -0.19 | -72.69% | ― | -88.01% | 76.01% | |
40 Underperform | $1.88M | -32.27 | -28.46% | ― | 3788.45% | 96.39% |
* Consumer Defensive Sector Average
CIMG
CIMG
0.04
-10.85
-99.66%
FARM
Farmer Brothers Company
1.26
-0.51
-28.81%
BTOG
Bit Origin
2.36
-6.53
-73.44%
PAVS
Paranovus Entertainment Technology
1.90
-1,618.10
-99.88%
COOT
Australian Oilseeds Holdings
0.58
-0.47
-44.57%
WYHG
Wing Yip Food Holdings Group Limited Sponsored ADR
0.48
-7.25
-93.85%
CIMG Corporate Events
Business Operations and StrategyDelistings and Listing ChangesFinancial DisclosuresM&A TransactionsPrivate Placements and FinancingProduct-Related AnnouncementsRegulatory Filings and Compliance
CIMG Reports Strong Growth and Expands Bitcoin Reserves
Positive
Mar 25, 2026
CIMG Inc., a Hong Kong-based digital health and sales development group, is pursuing a dual-track strategy in health consumer goods and computing power technology products across Asia, underpinned by AI-driven marketing and a cryptocurrency-focuse...
Business Operations and StrategyRegulatory Filings and Compliance
CIMG Expands Authorized Common Shares Through Charter Amendment
Neutral
Mar 12, 2026
On March 5, 2026, CIMG Inc. filed a Certificate of Amendment with the Nevada Secretary of State to significantly increase its authorized common stock, raising the limit from 600,000,000 to 2,000,000,000 shares at a par value of $0.00001 per share....
Delistings and Listing ChangesRegulatory Filings and Compliance
CIMG Faces Nasdaq Delisting, Begins OTC Market Trading
Negative
Mar 9, 2026
On March 4, 2026, CIMG Inc. received written notice that a Nasdaq Hearings Panel had determined to delist the company’s common stock for noncompliance with several Nasdaq listing rules, and trading in the stock was suspended at the open on M...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.